// App-Quantinova.ai

P355 2015 EPI : Mendelian Randomization Supports Causality Between Maternal Hyperglycemia and Fetal Metabolic Programming by Leptin Epigenetic Modulation

Researchers

Presenter

  • Catherine Allard

Principal Investigators

  • Veronique Desgagne

  • Luigi Bouchard

  • Julie Patenaude

  • Marilyn Lacroix

  • Laetitia Guillemette

  • Marie-Claude Battista

  • Myriam Doyon

  • Julie Menard

  • Jean-Luc Ardilouze

  • Patrice Perron

Medical Centers

  • Universite de Sherbrooke, Sherbrooke, QC, Canada

  • Harvard Pilgrim Health Care Institute, Boston, MA

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Gestational Diabetes

  • Hyperglycemia

  • Diabetes

  • Obesity

Biomarkers

  • Leptin

  • DNA methylation

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • observational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved